Tegafur–uracil is a safe alternative for the treatment of colorectal cancer in patients with partial dihydropyrimidine dehydrogenase deficiency: a proof of principle
Daniel de Iracema Gomes Cubero(Faculdade de Medicina do ABC), Auro del Giglio(Faculdade de Medicina do ABC), Patrícia Xavier Santi(Faculdade de Medicina do ABC), Ismael Dale C. G. Silva(Universidade Federal de São Paulo), Felipe Melo Cruz(Instituto Brasileiro de Controle do Câncer)
Cited by 17
Related Papers
Methylene blue in photodynamic therapy: From basic mechanisms to clinical applications
|Photodiagnosis and Photodynamic Therapy|2005|910
Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for HER2-negative advanced gastric cancer (KEYNOTE-859): a multicentre, randomised, double-blind, phase 3 trial
|The Lancet Oncology|2023|663
Niraparib and Abiraterone Acetate for Metastatic Castration-Resistant Prostate Cancer
|Journal of Clinical Oncology|2023|332
The biology of cancer-related fatigue: a review of the literature
|Supportive Care in Cancer|2015|305
Cancer-related fatigue: a practical review
|Annals of Oncology|2011|220